Date published: 2026-3-31

1-800-457-3801

SCBT Portrait Logo
Seach Input

ENO4 Activators

ENO4 activators are a class of chemical compounds that interact with the biological enzyme ENO4, which is a putative member of the enolase family of proteins. Enolases are a key group of enzymes that are involved in the glycolytic pathway, catalyzing the conversion of 2-phosphoglycerate to phosphoenolpyruvate. However, ENO4 activators are not typical substrates or inhibitors; they modulate the activity of ENO4 through a non-canonical mechanism that alters the enzyme's conformation or its interaction with other molecules within the cell. The biochemical pathways and mechanisms of action pertaining to ENO4 are less characterized compared to other members of the enolase family, which makes the study of ENO4 activators a novel and intriguing area of chemical biology.

The specific molecular characteristics of ENO4 activators often include features that allow them to engage with the enzyme at allosteric sites, which are regions on the protein surface distinct from the active site where catalysis occurs. Binding at these allosteric locations can induce changes in the enzyme's structure that either enhance or diminish its catalytic activity, depending on the nature of the interaction and the conformational changes induced. ENO4 activators may thus have a significant impact on the metabolic flux through pathways that are interconnected with the enzymatic reaction that ENO4 catalyzes. The study of these activators sheds light on the subtle nuances of metabolic regulation and offers insights into the intricate network of enzymatic interactions that sustain cellular metabolism. Despite our growing understanding, much remains to be discovered about the specific molecular interactions and regulatory mechanisms that ENO4 activators engage in, making them a rich subject for research in the field of biochemistry and molecular biology.

SEE ALSO...

Items 11 to 12 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin is another PI3K inhibitor that can indirectly enhance ENO4 activity by shifting cellular energy metabolism towards glycolysis, where ENO4 plays a crucial role.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$136.00
$446.00
114
(2)

Thapsigargin inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to increased cytosolic calcium levels, which might activate ENO4 through calcium-mediated signaling pathways.